DNA2 Stock Overview
Engages in the acquiring, leasing, and selling aircraft. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for DNA2 from our risk checks.
Doric Nimrod Air Two Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£1.43 |
| 52 Week High | UK£1.45 |
| 52 Week Low | UK£1.13 |
| Beta | 0.59 |
| 11 Month Change | -0.70% |
| 3 Month Change | 0.71% |
| 1 Year Change | 26.11% |
| 33 Year Change | 108.03% |
| 5 Year Change | -15.43% |
| Change since IPO | -33.72% |
Recent News & Updates
Doric Nimrod Air Two (LON:DNA2) Is Very Good At Capital Allocation
Aug 22
Doric Nimrod Air Two's (LON:DNA2) Earnings Offer More Than Meets The Eye
Dec 29Shareholder Returns
| DNA2 | GB Trade Distributors | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | 0.7% |
| 1Y | 26.1% | 19.5% | 6.1% |
Return vs Industry: DNA2 exceeded the UK Trade Distributors industry which returned 19.5% over the past year.
Return vs Market: DNA2 exceeded the UK Market which returned 6.1% over the past year.
Price Volatility
| DNA2 volatility | |
|---|---|
| DNA2 Average Weekly Movement | 1.3% |
| Trade Distributors Industry Average Movement | 4.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DNA2 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: DNA2's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | n/a | www.dnairtwo.co.uk |
Doric Nimrod Air Two Limited engages in the acquiring, leasing, and selling aircraft. The company was incorporated in 2011 and is based in St Peter Port, Guernsey.
Doric Nimrod Air Two Limited Fundamentals Summary
| DNA2 fundamental statistics | |
|---|---|
| Market cap | UK£175.83m |
| Earnings (TTM) | UK£58.22m |
| Revenue (TTM) | UK£108.88m |
3.0x
P/E Ratio1.6x
P/S RatioIs DNA2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNA2 income statement (TTM) | |
|---|---|
| Revenue | UK£108.88m |
| Cost of Revenue | UK£48.82m |
| Gross Profit | UK£60.05m |
| Other Expenses | UK£1.84m |
| Earnings | UK£58.22m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.47 |
| Gross Margin | 55.16% |
| Net Profit Margin | 53.47% |
| Debt/Equity Ratio | 1.3% |
How did DNA2 perform over the long term?
See historical performance and comparison